Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-070692

President & CEO acquired 126,050 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2021-12-16 Grant or award +126,050 601,500 D
Derivatives
ROBIN HOWARD W President & CEO 2021-12-16 Grant or award · Stock Option +223,750 223,750 D
Loading xslF345X03/doc4.xml…